The Pharmacy Times® Allergy resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.
What can we help you find?
Why is this patient listing ciprofloxacin as an allergy?
Pharmacists have a great opportunity to educate patients about how to stay healthy and counsel those in need of symptom relief about their allergy treatment options.
Pharmacists can provide easily accessible and economically reasonable solutions for patients who suffer from allergies.
Dupilumab is now the first biologic therapy approved for the patient population.
Inhaler misuse may result in more asthma attacks.
Future studies will help us determine who will most benefit from egg oral immunotherapy.
The needed-free treatment option, ARS-1, is designed to be easy-to-use, convenient and more reliable than other emergency epinephrine treatments for severe allergic reactions.
Teva’s Epinephrine Injection May Not Undercut Mylan’s on Price, but It Could Help in Addressing Shortages
Nasal congestion can negatively affect quality of life by interfering with day-to-day activities and disrupting sleep patterns.
A pair of pivotal Phase 3 placebo-controlled trials that evaluated dupilumab (Dupixent, Sanofi and Regeneron) for adults with inadequately-controlled chronic rhinosinusitis with nasal polyps met all primary and secondary endpoints.
National Penicillin Allergy Day highlights negative impact of Inaccurate allergy diagnoses.
One lot of Montelukast Sodium Tablets is being voluntarily recalled by Camber Pharmaceuticals, due to a safety risk for consumers.